The EIF2AK2 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited heterogeneous population of A-549 cells with targeted disruption of the EIF2AK2 gene. This polyclonal knockout product provides a reliable loss-of-function model for investigating EIF2AK2-mediated signaling in a lung adenocarcinoma epithelial background. The gene-edited population enables functional studies of the double-stranded RNA (dsRNA)-dependent protein kinase PKR without the need for single-cell cloning or pharmacological inhibition, preserving the genetic diversity inherent to the A-549 host line.
The host cell line A-549 is a widely used adherent epithelial cell line originally isolated from the lung adenocarcinoma of a 58-year-old Caucasian male. As a well-characterized model of human respiratory epithelium and lung cancer, A-549 cells are permissive to diverse viral infections and display intact innate immune and stress response pathways, making them suitable for dissecting PKR-dependent mechanisms in viral pathogenesis and oncogenic signaling.
EIF2AK2 encodes PKR, a serine/threonine kinase that is activated by dsRNA, interferons, and oxidative stress through autophosphorylation. Upon activation, PKR directly phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2??), leading to global translational attenuation and the integrated stress response. PKR also phosphorylates I??B to release NF-??B for nuclear translocation, thereby promoting pro-inflammatory gene expression. Downstream effectors include the transcription factor ATF4 and its pro-apoptotic target CHOP, as well as p53 and BCL2 family proteins mediating apoptosis. PKR interacts with regulatory partners such as PACT and TARBP2, and signals through TRAF family proteins and IRAK1 to modulate innate immunity.
In the A-549 lung adenocarcinoma context, ablation of EIF2AK2 disrupts the dsRNA-sensing axis and allows dissection of how PKR contributes to antiviral defense, interferon-responsive gene networks, and tumor cell survival. Given the dual role of PKR in growth control and cell death, the knockout cells are invaluable for probing how stress-driven translational shutdown intersects with oncogenic signaling. Moreover, the polyclonal nature preserves natural cell-to-cell variability, enabling the study of population-level responses to viral infection or chemotherapeutic stress without clonal bias.
Typical applications include western blot analysis of phospho-eIF2?? levels following dsRNA stimulation, RT-qPCR profiling of interferon-stimulated gene induction, and RNA sequencing to map transcriptome-wide changes upon stress. Immunofluorescence microscopy can monitor stress granule dynamics, while flow cytometry permits quantification of apoptosis via annexin V staining. Co-immunoprecipitation of PKR with PACT or STAT1 elucidates protein interaction networks, and dual luciferase reporter assays gauge NF-??B transcriptional activity. These polyclonal knockout cells serve as a versatile platform for antiviral innate immunity, translational control, and cancer signaling research. For technical inquiries, please contact Ascent Research.
